William Gutheil

Professor

University of Missouri Kansas City

United States

Research Interests

Explore related searches

Professors in United States Professors in Microbiology Microbiology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

William Gutheil is a Professor at the University of Missouri Kansas City, USA. His research focuses on electrochemical methods, drug metabolite analysis, and the development of synergistic drug combinations for combating antibiotic-resistant bacteria. Recent articles by Professor Gutheil explore topics such as electrochemical innovations, the anti-MRSA activity of various drug combinations, and the biochemical effects of vancomycin on resistant bacterial strains.

Articles (9)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Collaborators (1)

Mohammad Rafiee

Assistant Professor of Chemistry

University of Missouri Kansas City

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

William Gutheil

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

An Electrochemical Pipette for the Study of Drug Metabolite

Stereoselective Amine-omics Using Heavy Atom Isotope Labeled l- and d-Marfey’s Reagents

Electrosynthesis and Microanalysis in Thin Layer: An Electrochemical Pipette for Rapid Electrolysis and Mechanistic Study of Electrochemical Reactions

Electrosynthesis and Microanalysis in Thin Layer: An Electrochemical Pipette for Rapid Electrolysis and Mechanistic Study of Electrochemical Reactions

Synergistic Combinations of FDA-Approved Drugs with Ceftobiprole against Methicillin-Resistant Staphylococcus aureus

Screening the NCI diversity set V for anti-MRSA activity: cefoxitin synergy and LC-MS/MS confirmation of folate/thymidine biosynthesis inhibition

Library Screening for Synergistic Combinations of FDA-Approved Drugs and Metabolites with Vancomycin against VanA-Type Vancomycin-Resistant Enterococcus faecium

Correction to “Dimensionally Enhanced Antibacterial Library Screening”

Effect of Vancomycin on Cytoplasmic Peptidoglycan Intermediates and van Operon mRNA Levels in VanA-Type Vancomycin-Resistant Enterococcus faecium

Collaborators (1)

Mohammad Rafiee

Make your next move.